Chunyan Luan

1.3k total citations
22 papers, 708 citations indexed

About

Chunyan Luan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Chunyan Luan has authored 22 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Chunyan Luan's work include Renal and related cancers (6 papers), Renal cell carcinoma treatment (5 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Chunyan Luan is often cited by papers focused on Renal and related cancers (6 papers), Renal cell carcinoma treatment (5 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Chunyan Luan collaborates with scholars based in United States, China and Taiwan. Chunyan Luan's co-authors include Ximing J. Yang, Bin Tean Teh, Debra L. Zynger, Anita Gupta, Brian P. Adley, Pauline M. Chou, Fan Lin, Anjana V. Yeldandi, Leslie K. Diaz and Andrey Ugolkov and has published in prestigious journals such as International Journal of Cancer, Analytica Chimica Acta and The American Journal of Surgical Pathology.

In The Last Decade

Chunyan Luan

22 papers receiving 688 citations

Peers

Chunyan Luan

MB

PRM

SURGE

CR

ONCOL

Kenji Yorita Japan

Awatif Al‐Nafussi United Kingdom

Tilmann Lantzsch Germany

Sally A. Mullany United States

Nancy Chan United States

M Hiratsuka Japan

Kazutoshi Murata Japan

L. Kayitalire France

Xiuxin Han China

Magdalena Chechlińska Poland

Kenji Yorita Japan

Chunyan Luan

260 ×0.8

MB

160 ×0.6

PRM

178 ×0.8

SURGE

126 ×0.9

CR

202 ×1.6

ONCOL

Citations per year, relative to Chunyan Luan Chunyan Luan (= 1×) peers Kenji Yorita

Countries citing papers authored by Chunyan Luan

Since Specialization

Citations

This map shows the geographic impact of Chunyan Luan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunyan Luan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunyan Luan more than expected).

Fields of papers citing papers by Chunyan Luan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunyan Luan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunyan Luan. The network helps show where Chunyan Luan may publish in the future.

Co-authorship network of co-authors of Chunyan Luan

This figure shows the co-authorship network connecting the top 25 collaborators of Chunyan Luan. A scholar is included among the top collaborators of Chunyan Luan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunyan Luan. Chunyan Luan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Lai, Xin, Chunyan Luan, Anja Wessely, et al.. (2025). SOX10 , MITF , and microRNAs : Decoding their interplay in regulating melanoma plasticity. International Journal of Cancer. 157(7). 1277–1293. 1 indexed citations

2.

Chen, Xiaohong, Shuo Cao, Liye Tao, et al.. (2024). Establishment of MS LOC platform and its pilot application in clinical lipidomics. Talanta. 285. 127314–127314. 1 indexed citations

3.

Luan, Chunyan, et al.. (2023). Thalidomide Alleviates Apoptosis, Oxidative Damage and Inflammation Induced by Pemphigus Vulgaris IgG in HaCat Cells and Neonatal Mice Through MyD88. Drug Design Development and Therapy. Volume 17. 2821–2839. 5 indexed citations

4.

Chen, Juan, et al.. (2021). Transcriptome Sequencing Identifies PLAUR as an Important Player in Patients With Dermatomyositis-Associated Interstitial Lung Disease. Frontiers in Genetics. 12. 784215–784215. 9 indexed citations

5.

Wang, Tao, et al.. (2020). High throughput lipid profiling for subtype classification of hepatocellular carcinoma cell lines and tumor tissues. Analytica Chimica Acta. 1107. 92–100. 11 indexed citations

6.

Luan, Chunyan, et al.. (2018). PLCE1Promotes the Invasion and Migration of Esophageal Cancer Cells by Up-Regulating the PKCα/NF-κB Pathway. Yonsei Medical Journal. 59(10). 1159–1159. 16 indexed citations

7.

Tretiakova, Maria, Debra L. Zynger, Chunyan Luan, et al.. (2014). Glypican 3 overexpression in primary and metastatic Wilms tumors. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 466(1). 67–76. 20 indexed citations

8.

Liu, Zhigang, et al.. (2012). [Electrocardiograph resembles acute ST segment elevation myocardial infarction in pheochromocytoma crisis: a case report].. PubMed. 40(5). 437–8. 1 indexed citations

9.

Zhang, Zhongfa, See‐Tong Pang, Chunyan Luan, et al.. (2011). FXYD3: A Promising Biomarker for Urothelial Carcinoma. Biomarker Insights. 6. BMI.S6487–BMI.S6487. 21 indexed citations

10.

Ugolkov, Andrey, et al.. (2010). Expression analysis of putative stem cell markers in human benign and malignant prostate. The Prostate. 71(1). 18–25. 56 indexed citations

11.

Zynger, Debra L., John C. McCallum, Chunyan Luan, Pauline M. Chou, & Ximing J. Yang. (2010). Glypican 3 has a higher sensitivity than alpha‐fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns. Histopathology. 56(6). 750–757. 51 indexed citations

12.

Liu, Fuguo, et al.. (2009). Relationships between serum levels of vascular endothelial growth factor and endostatin in patients with gastric carcinoma and clinical pathological characteristics. Shandong yiyao. 49(25). 11–13. 1 indexed citations

13.

Wei, Jian-Jun, Jingjing Wu, Chunyan Luan, et al.. (2009). HMGA2: A Potential Biomarker Complement to P53 for Detection of Early-stage High-grade Papillary Serous Carcinoma in Fallopian Tubes. The American Journal of Surgical Pathology. 34(1). 18–26. 50 indexed citations

14.

Zynger, Debra L., Anita Gupta, Chunyan Luan, et al.. (2007). Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases. Human Pathology. 39(2). 224–230. 62 indexed citations

15.

Sitterding, Stephanie, Chunyan Luan, Feng Chen, et al.. (2007). αB-crystallin: A novel marker of invasive basal-like and metaplastic breast carcinomas. Annals of Diagnostic Pathology. 12(1). 33–40. 50 indexed citations

16.

Zynger, Debra L., et al.. (2006). Glypican 3: A Novel Marker in Testicular Germ Cell Tumors. The American Journal of Surgical Pathology. 30(12). 1570–1575. 132 indexed citations

17.

Wang, Kim L., David M. Weinrach, Chunyan Luan, et al.. (2006). Renal papillary adenoma—a putative precursor of papillary renal cell carcinoma. Human Pathology. 38(2). 239–246. 43 indexed citations

18.

Adley, Brian P., Anita Gupta, Fan Lin, et al.. (2006). Expression of Kidney-Specific Cadherin in Chromophobe Renal Cell Carcinoma and Renal Oncocytoma. American Journal of Clinical Pathology. 126(1). 79–85. 37 indexed citations

19.

Adley, Brian P., Anita Gupta, Fan Lin, et al.. (2006). Expression of Kidney-Specific Cadherin in Chromophobe Renal Cell Carcinoma and Renal Oncocytoma. American Journal of Clinical Pathology. 126(1). 79–85. 39 indexed citations

20.

Patton, Kurt T., Liang Cheng, Veronica Papavero, et al.. (2005). Benign metastasizing leiomyoma: clonality, telomere length and clinicopathologic analysis. Modern Pathology. 19(1). 130–140. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact